There were 463 press releases posted in the last 24 hours and 430,744 in the last 365 days.

A Spotlight on Pharmaceutical Parallel Trade Post BREXIT

Parallel Trade 2017

Parallel Trade 2017

SMi Reports: Key questions addressed at 11th annual industry summit next month

LONDON, ENGLAND, UNITED KINGDOM, January 16, 2017 /EINPresswire.com/ -- SMi Group will open doors to host the only event of its kind focused on pharmaceutical parallel trade when it returns to Central London for its 11th year on 6th and 7th February.

The speaker panel for Parallel Trade 2017 will feature a selection of pharmaceutical manufacturers and regulators to address questions such as:

• What key factors determine the flow of pharmaceutical products in Europe and how will these change post Brexit?
• How can wholesalers tackle uncertainty until trading arrangements are finalised?
• Exactly one year - what progress has been made on the new EU Falsified Medicine Directive?
• What are the implications of parallel trade for low-price countries and when must governments intervene?
• Which categories of pharmaceutical products offer highest margins for traders?
• How can the industry overcome common obstacles presented by intellectual property, competition, medicines sold online and regulation?
• How can traders collaborate to improve supply chain safety?

Some of those presenting will include:

The Association of the British Pharmaceutical Industry (Dr Rick Greville, Director Distribution & Supply), Shire International GmbH (Eric Noehrenberg, Director, Regional Market Access Lead, Latin America), Delfarma (Tomasz Dzitko, President), European Association for Euro-Pharmaceutical Companies (Heinz Kobelt, Director European Affairs), ISPOR (Vladimir Zah, Health Economics Consultant), Abacus Medicine (Flemming Wagner, CEO), IMS Health (Alexey Savin, Principal Russia and CIS), Arnold & Porter (UK) LLP (Kathy Osgerby, Associate, and Karoline Zwierzynska, Associate), Europe Economics (Dermot Glynn, Senior Advisor), European Alliance for Access to Save Medicines (Mike Isles, Executive Director), Research Health (Dr Andrew Stainthorpe, Director Market Access and Managed Entry).

Further information including a detailed agenda and full speaker line-up is available at:
www.parallel-trade.com

11th Annual Event: Parallel Trade 2017
Place: 6th & 7th Feb
Place: Holiday Inn Kensington Forum, London UK

--- end ---

Contact Information:

For all media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk
For delegate enquiries contact Fateja Begum on Tel: +44 (0)20 7827 6184 / Email: fbegum@smi-online.co.uk
To sponsor, speak or exhibit at the conference, contact Alia Malick on Tel: +44 (0)20 7827 6168 /
Email: amalick@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Teri Arri
SMi Group
2078276000
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.